Analysts at Kaufman Bros maintain their “buy” rating on IPC The Hospitalist Company Inc (NASDAQ:
IPCM). The target price for IPCM has been raised from $36 to $43.
IPCM shares fell 0.18% to close at $38.20 yesterday.
More Analyst Ratings here© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
